EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular profiling of the hippocampus of children with autism spectrum disorder

Lindsay E Rexrode, Joshua Hartley, Kurt C Showmaker iD, Lavanya Challagundla, Michael W Vandewege, Brigitte E Martin, Estelle Blair, Ratna Bollavarapu, Rhenius B Antonyraj, Keauna Hilton, Alex Gardiner, Jake Valeri und 4 weitere

Molecular Psychiatry · 2024-07 · 29 (7) · 1968-1979

DOI: 10.1038/s41380-024-02441-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Psychiatry, online erschienen am 14.02.2024. Verfasst von Lindsay E Rexrode und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Human Behavior, University of Mississippi Medical School, Jackson, MS, USA. Hauptthemen laut MEDLINE: Hippocampus, Autism Spectrum Disorder, Chondroitin Sulfate Proteoglycans. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several lines of evidence point to a key role of the hippocampus in Autism Spectrum Disorders (ASD). Altered hippocampal volume and deficits in memory for person and emotion related stimuli have been reported, along with enhanced ability for declarative memories. Mouse models have demonstrated a critical role of the hippocampus in social memory dysfunction, associated with ASD, together with decreased synaptic plasticity. Chondroitin sulfate proteoglycans (CSPGs), a family of extracellular matrix molecules, represent a potential key link between neurodevelopment, synaptic plasticity, and immune system signaling. There is a lack of information regarding the molecular pathology of the hippocampus in ASD. We conducted RNAseq profiling on postmortem human brain samples containing the hippocampus from male children with ASD ( n = 7) and normal male children (3–14 yrs old), ( n = 6) from the NIH NeuroBioBank. Gene expression profiling analysis implicated molecular pathways involved in extracellular matrix organization, neurodevelopment, synaptic regulation, and immune system signaling. qRT-PCR and Western blotting were used to confirm several of the top markers identified. The CSPG protein BCAN was examined with multiplex immunofluorescence to analyze cell-type specific expression of BCAN and astrocyte morphology. We observed decreased expression of synaptic proteins PSD95 ( p < 0.02) and SYN1 ( p < 0.02), increased expression of the extracellular matrix (ECM) protease MMP9 ( p < 0.03), and decreased expression of MEF2C ( p < 0.03). We also observed increased BCAN expression with astrocytes in children with ASD, together with altered astrocyte morphology. Our results point to alterations in immune system signaling, glia cell differentiation, and synaptic signaling in the hippocampus of children with ASD, together with alterations in extracellular matrix molecules. Furthermore, our results demonstrate altered expression of genes implicated in genetic studies of ASD including SYN1 and MEF2C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HippocampusAutism Spectrum DisorderChondroitin Sulfate ProteoglycansHumansChildMaleAdolescentChild, PreschoolMEF2 Transcription FactorsGene Expression ProfilingAstrocytesNeuronal PlasticityMatrix Metalloproteinase 9Extracellular MatrixMembrane GlycoproteinsReceptor, trkB

Substanzen

Chondroitin Sulfate ProteoglycansMEF2 Transcription FactorsMEF2C protein, humanMatrix Metalloproteinase 9tropomyosin-related kinase-B, humanMembrane GlycoproteinsReceptor, trkB

Autor:innen und Institutionen

  • Department of Psychiatry and Human Behavior, University of Mississippi Medical School, Jackson, MS, USA.
  • Dasomics LLC, Madison, MS, USA.
  • Department of Cell and Molecular Biology, University of Mississippi Medical School, Jackson, MS, USA.
  • Program in Neuroscience, University of Mississippi Medical School, Jackson, MS, USA.
  • Institute of Neuro-Immune Medicine, Nova Southeastern University, Clearwater, FL, USA.
  • Department of Immunology, Tufts University School of Medicine, Boston, MA, USA.

ORCID-Profile: Kurt C Showmaker, Harry Pantazopoulos

Förderung

  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)

Zitieren

APA

Rexrode, L. E., Hartley, J., Showmaker, K. C., Challagundla, L., Vandewege, M. W., Martin, B. E., Blair, E., Bollavarapu, R., Antonyraj, R. B., Hilton, K., Gardiner, A., Valeri, J., Gisabella, B., Garrett, M. R., Theoharides, T. C., & Pantazopoulos, H. (2024). Molecular profiling of the hippocampus of children with autism spectrum disorder. Molecular Psychiatry, 29(7), 1968-1979. https://doi.org/10.1038/s41380-024-02441-8

Vancouver

Rexrode LE, Hartley J, Showmaker KC, Challagundla L, Vandewege MW, Martin BE, et al. Molecular profiling of the hippocampus of children with autism spectrum disorder. Molecular Psychiatry. 2024;29(7):1968-1979. doi:10.1038/s41380-024-02441-8

BibTeX
@article{Rexrode2024,
  author = {Rexrode, Lindsay E and Hartley, Joshua and Showmaker, Kurt C and Challagundla, Lavanya and Vandewege, Michael W and Martin, Brigitte E and Blair, Estelle and Bollavarapu, Ratna and Antonyraj, Rhenius B and Hilton, Keauna and Gardiner, Alex and Valeri, Jake and Gisabella, Barbara and Garrett, Michael R and Theoharides, Theoharis C and Pantazopoulos, Harry},
  title = {Molecular profiling of the hippocampus of children with autism spectrum disorder},
  journal = {Molecular Psychiatry},
  year = {2024},
  volume = {29},
  number = {7},
  pages = {1968--1979},
  doi = {10.1038/s41380-024-02441-8}
}
Kostenlos starten →